BVS - Company ID 0001665988
The table below shows Bioventus Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $51.24M | $41.58M | $36.96M | $31.81M | $43.93M |
| Short-term investments | - | - | - | - | - |
| Receivables | $128.30M | $127.39M | $122.79M | $136.65M | $124.96M |
| Inventory | $82.24M | $92.47M | $91.33M | $85.41M | $61.69M |
| Total current assets | $272.84M | $275.61M | $268.00M | $272.57M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $263.10M |
| Property, plant & equipment | - | - | - | $27.65M | $22.98M |
| Goodwill | $7.46M | $7.46M | $7.46M | $13.76M | $147.62M |
| Total assets | $683.56M | $727.96M | $810.91M | $1.37B | $1.23B |
| Accounts payable | $10.93M | $23.69M | $23.04M | $37.55M | $16.91M |
| Total current liabilities | $160.38M | $210.40M | $175.50M | $304.02M | $180.86M |
| Long-term debt | $278.95M | $308.29M | $367.00M | $385.01M | $339.64M |
| Total liabilities | $455.11M | $542.35M | $589.79M | $1.03B | $692.07M |
| Retained earnings | -$334.93M | -$355.08M | -$321.54M | -$165.31M | -$6.60M |
| Total equity | $184.10M | $147.94M | $173.59M | $316.58M | $458.92M |